Patents by Inventor Syed Sohail Ahmed

Syed Sohail Ahmed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A CATHEPSIN S INHIBITOR AGAINST THE FORMATION OF ANTI-DRUG ANTIBODIES
    Publication number: 20210315863
    Abstract: The present invention relates in particular to a cathepsin S inhibitor for use in a method for reducing or preventing the formation of anti-drug antibodies (ADA) against a therapeutic agent in a subject who is receiving a treatment with said therapeutic agent.
    Type: Application
    Filed: March 18, 2021
    Publication date: October 14, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Christian KLEIN, Fabrice Alain Andre KOLB, Marianne Manchester YOUNG, Syed Sohail AHMED, Juliana MATTOS DE ALMEIDA BESSA
  • AVOIDING NARCOLEPSY RISK IN INFLUENZA VACCINES
    Publication number: 20190184007
    Abstract: The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.
    Type: Application
    Filed: March 6, 2019
    Publication date: June 20, 2019
    Inventors: Syed Sohail AHMED, Lawrence Steinman, Wayne Volkmuth
  • AVOIDING NARCOLEPSY RISK IN INFLUENZA VACCINES
    Publication number: 20170216425
    Abstract: The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.
    Type: Application
    Filed: October 4, 2016
    Publication date: August 3, 2017
    Inventors: Syed Sohail Ahmed, Lawrence Steinman, Wayne Volkmuth
  • Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
    Patent number: 9149459
    Abstract: The use of an S1P receptor modulator of the formula (Ia) or (Ib) wherein the meaning of the different residues is that indicated in claim 14, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis, dermatomyositis and nerve-muscle diseases e.g. muscular dystrophies and inclusion body myositis.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: October 6, 2015
    Assignee: Novartis AG
    Inventors: Syed Sohail Ahmed, Marco Londei, Timothy Wright, Peter Gergely
  • AVOIDING NARCOLEPSY RISK IN INFLUENZA VACCINES
    Publication number: 20140335116
    Abstract: The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines.
    Type: Application
    Filed: May 12, 2014
    Publication date: November 13, 2014
    Applicant: NOVARTIS AG
    Inventors: Syed Sohail Ahmed, Lawrence Steinman, Wayne Volkmuth
  • SPHINGOSINE 1 PHOSPHATE RECEPTOR MODUATORS AND THEIR USE TO TREAT MUSCLE INFLAMMATION
    Publication number: 20110124620
    Abstract: The use of an S1P receptor modulator of the formula (Ia) or (Ib) wherein the meaning of the different residues is that indicated in claim 14, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis, dermatomyositis and nerve-muscle diseases e.g. muscular dystrophies and inclusion body myositis.
    Type: Application
    Filed: July 22, 2009
    Publication date: May 26, 2011
    Inventors: Syed Sohail Ahmed, Marco Londel, Timothy Wright, Peter Gergely